详情页 - 聚合机构库演示平台

当前位置：首页 > 详情页

Sunitinib in the Treatment of Unresectable or Metastatic Gastroenteropancreatic Neuroendocrine Neoplasm: A Multicenter Retrospective Study in China

文献详情

资源类型：

WOS体系：

收录情况： ◇ SCIE ◇ CPCI(ISTP)

作者：

单位： [1]Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China [2]Department of Traditional Chinese Medicine Oncology, China-Japan Friendship Hospital, Beijing, China [3]Pancreatic Cancer Institute, Fudan University [4]Department of Pancreas Surgery, Fudan University Shanghai Cancer Center, Shanghai, China [5]Department of Gastroenterological Oncology, Peking University Cancer Hospital, Beijing, China [6]Department of General Surgery, Changzheng Hospital, Second Military Medical University, Shanghai, China [7]Department of Gastric and Pancreatic Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China

出处：

ISSN：

关键词： Gastroenteropancreatic neuroendocrine neoplasm Sunitinib Treatment

语种：

WOS：

中科院(CAS)分区：

出版当年[2015]版：

大类 | 2 区医学

小类 | 3 区内分泌学与代谢 3 区神经科学

最新[2025]版：

大类 | 3 区医学

小类 | 3 区内分泌学与代谢 3 区神经科学

JCR分区：

出版当年[2014]版：

Q1 ENDOCRINOLOGY & METABOLISM Q1 NEUROSCIENCES

最新[2023]版：

Q2 ENDOCRINOLOGY & METABOLISM Q2 NEUROSCIENCES

影响因子： 最新[2023版] 3.2 最新五年平均[2021-2025] 3.6 出版当年[2014版] 4.373 出版当年五年平均[2010-2014] 3.615 出版前一年[2013版] 4.934 出版后一年[2015版] 2.583

第一作者：

第一作者单位： [1]Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Sunitinib is effective and tolerable in Chinese patients with advanced pancreatic neuroendocrine tumors: a multicenter retrospective study in China [2]HDM2 inhibition augments the antitumor and antiangiogenic effects of sunitinib by suppressing sunitinib-induced SDF-1 expression and tumor recruitment of CD11b/Gr1+MDSC in RCC xenografts [3]Efficacy Prediction Using Computed Tomography for Patients with Pancreatic Neuroendocrine Tumors Receiving Sunitinib [4]Sunitinib facilitates metastatic breast cancer spreading by inducing endothelial cell senescence [5]Efficacy and Safety of Sunitinib in Patients with Well-Differentiated Pancreatic Neuroendocrine Tumours [6]Special issue "the advance of solid tumor research in China": Prediction of Sunitinib efficacy using computed tomography in patients with pancreatic neuroendocrine tumors [7]Sunitinib reduces the infection of SARS-CoV, MERS-CoV and SARS-CoV-2 partially by inhibiting AP2M1 phosphorylation [8]Effects of HDM2 antagonism on sunitinib resistance, p53 activation, SDF-1 induction, and tumor infiltration by CD11b(+)/Gr-1(+) myeloid derived suppressor cells [9]Diagnosis and Treatment of Five Pain-Related Conditions in Urban China: A Population-Based Cross-Sectional National Health and Wellness Survey [10]结直肠癌肝转移的规范化诊断和治疗